Device Therapy In Heart Failure Population In New Zealand

Show simple item record

dc.contributor.advisor Doughty, R en
dc.contributor.advisor Lever, N en
dc.contributor.author Looi, Khang Li en
dc.date.accessioned 2019-12-02T01:29:34Z en
dc.date.issued 2019 en
dc.identifier.uri http://hdl.handle.net/2292/49279 en
dc.description.abstract Heart failure (HF) is a major burden in developed and developing countries. It is known that HF patients are at risk of sudden cardiac death (SCD). The research presented within this thesis aims to add to the current knowledge in understanding the use of implantable cardioverterdefibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in HF patients in New Zealand and to improve the awareness of these evidence-based device-therapy in the contemporary management of HF patients. Chapter 1 comprises a literature overview on providing background on SCD in HF patients and the role of ICDs in preventing SCD in HF management. Chapter 2 contains a literature review on CRT use in the management of selected HF patients. Chapter 3 describes a study that examines the use of cardiac resynchronisation therapypacemaker (CRT-P) versus cardiac resynchronisation therapy-defibrillator (CRT-D) in patients with impaired left ventricular ejection fraction (LVEF). Chapter 4 describes a study that evaluates the role of a simple risk score to identify HF patients who should have CRT-D versus those who should be treated with a CRT-P even when fulfilling ICD implantation criteria. Chapter 5 reports two observational studies describing the trends and utilisations as well as the outcomes of HF patients with ICD/CRT-D and CRT-P in the Northern Region of New Zealand. A third study reported the gender differences in the use of these devices in New Zealand. An overview of quality of life (QoL) of HF patients has been presented in Chapter 6 followed by a study that describe the burden of hospitalisations, using the novel concept of "Days alive and out of hospital" (DAOH) in HF patients implanted with CRT devices in the Northern Region of New Zealand. The final study in Chapter 6 describes the outcomes of HF patients with primary prevention ICD/CRT-D who underwent unit generator replacement due to battery depletion. Chapter 7 summarises the results of the studies and discusses the wider context and clinical relevance of the findings, as well as making some future research recommendations. en
dc.publisher ResearchSpace@Auckland en
dc.relation.ispartof PhD Thesis - University of Auckland en
dc.relation.isreferencedby UoA99265200511002091 en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/nz/ en
dc.title Device Therapy In Heart Failure Population In New Zealand en
dc.type Thesis en
thesis.degree.discipline Medicine en
thesis.degree.grantor The University of Auckland en
thesis.degree.level Doctoral en
thesis.degree.name PhD en
dc.rights.holder Copyright: The author en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.elements-id 788168 en
pubs.record-created-at-source-date 2019-12-02 en
dc.identifier.wikidata Q112200829


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics